Abstract: The present invention relates to compositions and methods for modulating Toll-like receptors (TLRs) for enhancing survival of activated CD4+ T cells. The enhanced survival of activated CD4+ T cells provides a means for regulating an immune response.
Type:
Application
Filed:
June 15, 2006
Publication date:
September 3, 2009
Applicant:
THE TRUSTEES OF THE UNIVERISTY OF PENNSYLVANIA CNETER FOR TECHNOLOGY TRANSFER